First-line panitumumab combined with FOLFIRI for the treatment of patients with metastatic colorectal cancer (mCRC): data from a phase II, single-arm, multicentre study (20060314)

被引：0
|
作者：
Karthaus, M. [1 ]
Greil, R. [2 ]
Mineur, L. [3 ]
Letocha, H. [4 ]
Thaler, J. [6 ]
Hofheinz, R. [5 ]
Fernebro, E. [7 ]
Gamelin, E. [8 ]
DeCosta, L. [9 ]
Koehne, C.-H. [10 ]
机构：
[1] Klin Hamatol & Onkol, Klinikum Neuperlach, Munich, Germany
[2] Innere Med Klin 3, Salzburg, Austria
[3] Int Sainte Catherine, Avignon, France
[4] Onkol Kliniken, Vasteras, Sweden
[5] Klinikum Mannheim, Mannheim, Germany
[6] Klinikum Wels Grieskirchen, Wels, Austria
[7] Onkol Kliniken, Helsingborg, Sweden
[8] Ctr Paul Papin, Angers, France
[9] Amgen Ltd, Uxbridge, Middx, England
[10] Onkol Klinikum Oldenburg, Oldenburg, Germany
来源：
ONKOLOGIE | 2010年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：62 / 62
页数：1
相关论文
共 50 条
  • [1] PRIMARY ANALYSIS OF A PHASE II, SINGLE-ARM STUDY (20060314) COMBINING PANITUMUMAB WITH FOLFIRI IN THE FIRST LINE TREATMENT OF PATIENTS (PTS) WITH METASTATIC COLORECTAL CANCER (MCRC)
    Koehne, C. H.
    Mineur, L.
    Greil, R.
    Letocha, H.
    Thaler, J.
    Hofheinz, R.
    Fernebro, E.
    Gamelin, E.
    Wright, L.
    Karthaus, M.
    ANNALS OF ONCOLOGY, 2010, 21 : I51 - I51
  • [2] Updated analysis of a phase II study (20060314) of panitumumab (pmab) with FOLFIRI as first-line treatment of patients (pts) with metastatic colorectal cancer (mCRC)
    Greil, R.
    Letocha, H.
    Gamelin, E.
    Thaler, J.
    Hofheinz, R.
    Mineur, L.
    Fernebro, E.
    Karthaus, M.
    Wright, L.
    Koehne, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [3] Interim analysis of epidermal-growth factor receptor (EGFR) expression in a single-arm, phase II, first-line study (20060314) of panitumumab with FOLFIRI in the management of metastatic colorectal cancer (mCRC)
    Koehne, C.
    Hofheinz, R.
    Mineur, L.
    Letocha, H.
    Greil, R.
    Thaler, J.
    Gamelin, E.
    Fernebro, E.
    Wright, L.
    Karthaus, M.
    EJC SUPPLEMENTS, 2009, 7 (02): : 343 - 344
  • [4] Panitumumab (pmab) with FOLFIRI as first-line treatment of patients (pts) with metastatic coloretal cancer (mCRC): Resections and curative surgery in a phase II single arm, multicenter study (20060314)
    Hofheinz, R.
    Mineur, L.
    Greil, R.
    Kohne, C.
    Letocha, H.
    Thaler, J.
    Fernebro, E.
    Gamelin, E.
    DeCosta, L.
    Karthaus, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [5] Skin toxicity and quality of life in patients with metastatic colorectal cancer during first-line panitumumab plus FOLFIRI treatment in a single-arm phase II study
    Thaler, Josef
    Karthaus, Meinolf
    Mineur, Laurent
    Greil, Richard
    Letocha, Henry
    Hofheinz, Ralf
    Fernebro, Eva
    Gamelin, Erick
    Banos, Ana
    Koehne, Claus-Henning
    BMC CANCER, 2012, 12
  • [6] Skin toxicity and quality of life in patients with metastatic colorectal cancer during first-line panitumumab plus FOLFIRI treatment in a single-arm phase II study
    Josef Thaler
    Meinolf Karthaus
    Laurent Mineur
    Richard Greil
    Henry Letocha
    Ralf Hofheinz
    Eva Fernebro
    Erick Gamelin
    Ana Baños
    Claus-Henning Köhne
    BMC Cancer, 12
  • [7] PATIENT-REPORTED OUTCOMES (PRO) IN A FIRST-LINE STUDY (20060314) OF PANITUMUMAB plus FOLFIRI IN PATIENTS WITH METASTATIC COLORECTAL CANCER (MCRC)
    Karthaus, M.
    Resch, G.
    Mineur, L.
    Hofheinz, R.
    Greil, R.
    Letocha, H.
    Fernebro, E.
    Gamelin, E.
    DeCosta, L.
    Koehne, C.
    ANNALS OF ONCOLOGY, 2010, 21 : 75 - 75
  • [8] Epidermal growth factor receptor (EGFR) inhibitor-related skin toxicity: Review of interim data from a phase II study (20060314) of panitumumab (pmab) with FOLFIRI in the first-line treatment of metastatic colorectal cancer (mCRC)
    Karthaus, M.
    Hofheinz, R.
    Mineur, L.
    Letocha, H.
    Greil, R.
    Thaler, J.
    Gamelin, E.
    Wright, L.
    Kohne, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [9] A phase III comparison of FOLFOXIRI to FOLFIRI as first-line treatment of metastatic colorectal cancer (MCRC)
    Masi, G.
    Brunetti, I
    Murr, R.
    Benedetti, G.
    Evangelista, W.
    Picone, V
    Chiara, S.
    Merlano, M.
    Vitello, S.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2006, 17 : 22 - 23
  • [10] MANAGEMENT OF EPIDERMAL-GROWTH FACTOR RECEPTOR INHIBITOR-RELATED SKIN TOXICITY: A FIRST-LINE, PHASE II STUDY (20060314) OF PANITUMUMAB WITH FOLFIRI IN THE TREATMENT OF METASTATIC COLORECTAL CANCER
    Meinolf, K.
    Gabriele, S.
    Ralf, H.
    Mineur, L.
    Letocha, H.
    Greil, R.
    Thaler, J.
    Gamelin, E.
    Femebro, E.
    Wright, L.
    Koehne, C.
    ANNALS OF ONCOLOGY, 2009, 20 : 12 - 12
12345